Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

Roche Holding AG is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

A multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...

Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are overprescribing them and some patients are taking them in secret.

Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology Approval represents critical advancement ...

Pharma companies' earnings outlook is being obscured by concerns over revived "most-favored-nation" drug pricing rules in the ...

A press release from IBJ announces the release of their fourth annual Indiana 250 list of influential Hoosiers.

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...